Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).
Term:percentage of study population displaying chronic experimental autoimmune encephalomyelitis at a point in time
go back to main search page
Accession:CMO:0001892 term browser browse the term
Definition:A measurement in which the number of individuals in a study population that display, i.e., are manifesting symptoms of or have been diagnosed with, chronic experimental autoimmune encephalomyelitis (EAE) at a point in time are compared to the total number of individuals in the study population. Often expressed as a percentage but could be expressed as a ratio. EAE is an animal model of brain inflammation in which inflammation is induced through immunization of the animal with central nervous system antigens or by the passive transfer of autoreactive T cells. Chronic EAE is a variant of EAE characterized by a long duration and slow, constant progression.
Comment:For disease characterized by repeated symptomatic attacks followed by complete or almost complete improvement, use the term for relapsing-remitting experimental autoimmune encephalomyelitis.
Synonyms:related_synonym: chronic EAE prevalence;   percentage of study population displaying chronic EAE at a point in time


show annotations for term's descendants           Sort by:
Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 2369
    disease population measurement 57
      disease incidence/prevalence measurement 57
        nervous system disease incidence/prevalence measurement 25
          experimental autoimmune encephalomyelitis incidence/prevalence measurement 16
            percentage of study population displaying experimental autoimmune encephalomyelitis at a point in time 0
              percentage of study population displaying chronic experimental autoimmune encephalomyelitis at a point in time 0
paths to the root